Related Experiment Video
Updated: Jun 13, 2026

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
[Recent advances in novel biomarkers for severity assessment and prognostic prediction in severe acute pancreatitis]
1Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, China. Corresponding author: Chen Tao,
Abstract:
Severe acute pancreatitis (SAP) is a critical condition frequently encountered in the intensive care unit (ICU), with high incidence, mortality, and healthcare costs. The complexity and difficulty in predicting its severity and prognosis stem from multiple etiologies, dynamic disease progression, multi-organ dysfunction, and variations in clinical management. Traditional scoring systems and indicators often lack timeliness and adequate predictive performance. Therefore, there is an urgent need for novel, reliable, and easily measurable biomarkers to seize the valuable "window of opportunity" and to promote a shift in clinical management from passive response to proactive intervention. This review summarizes recent advances in biomarker research related to the severity and prognosis of SAP, aiming to provide new perspectives for the development of predictive tools and models.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Pathophysiology
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction

